XML 28 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2020 $ 43 $ 46,366 $ (90,180) $ (43,771)
Beginning balance ,shares at Dec. 31, 2020 42,973,462      
Common stock issued $ 1 9,623   9,624
Common stock issued (in shares) 915,454      
Reclassification of settlement liability upon issuance of warrant   60,852   60,852
Effect of Merger and recapitalization, net of redemptions and issuance costs $ 2 (26,618)   (26,616)
Effect of Merger and recapitalization, net of redemptions and issuance costs (in shares) 2,529,730      
Common stock issued pursuant to PIPE financing, net of issuance costs (in shares) 1,000,000      
Common stock issued pursuant to PIPE financing, net of issuance costs $ 1 8,099   8,100
Common stock issued for advisor services   4,850   4,850
Common stock issued for advisor services (in shares) 200,000      
Modification of option awards pursuant to Merger   1,015   1,015
Modification of warrants pursuant to Merger   2,330   2,330
Common stock and warrants issued in private placement, net of issuance costs $ 3 27,356   27,359
Common stock and warrants issued in private placement, net of issuance costs (in shares) 2,727,273      
Issuance of common stock for exercise of warrants and Unit Purchase Options $ 4 16,695   $ 16,699
Issuance of common stock for exercise of warrants and Unit Purchase Options (in shares) 3,830,586     516,025
Common stock issued for consulting services $ 5 48,982   $ 48,987
Common stock issued for consulting services (in shares) 4,634,045     4,834,045
Stock-based compensation   4,440   $ 4,440
Net income (loss)     (93,063) (93,063)
Ending balance at Dec. 31, 2021 $ 59 203,990 (183,243) 20,806
Ending balance ,shares at Dec. 31, 2021 58,810,550      
Common stock and warrants issued in private placement, net of issuance costs $ 8 22,694   $ 22,702
Common stock and warrants issued in private placement, net of issuance costs (in shares) 7,824,727     7,824,727
Issuance of common stock for exercise of warrants and Unit Purchase Options   10   $ 10
Issuance of common stock for exercise of warrants and Unit Purchase Options (in shares) 49,605     49,605
Common stock issued for consulting services   17   $ 17
Common stock issued for consulting services (in shares) 6,037      
Restricted stock awards granted $ 1 (1)    
Restricted stock awards granted (in shares) 1,000,000      
Earnout Stock Retired During Period, Value $ (1) 1    
Earnout Stock Retired During Period, Shares 1,247,930      
Stock-based compensation   3,628   3,628
Net income (loss)     (39,754) (39,754)
Ending balance at Dec. 31, 2022 $ 67 $ 230,339 $ (222,997) $ 7,409
Ending balance ,shares at Dec. 31, 2022 66,442,989